Abstract
Studies have shown that active tuberculosis is associated with elevated systemic inflammatory markers like ESR, CRP, IL-6, SAA, TNF-a, IFN-γ and many others. We aim to evaluate the serum levels of serum CRP and IFN-γ in active pulmonary tuberculosis (APTB) and the possible effects of ATT treatment on these cytokine levels. A total of 54 patients with the diagnosis of APTB and 20 healthy volunteers as controls were taken for study. The study showed that patients of APTB have significantly elevated baseline levels of serum CRP levels (mean+SD) of 21.71± 6.37mg/dl and serum IFN-γ (mean+SD) of 41.47±43.25 pg/ml compared to controls with serum CRP levels of < 5mg/dl and serum IFN-γ of 1.81±1.6pg/ml pg/ml respectively. Both serum CRP and serum IFN-γ levels decreased significantly with duration of treatment with CRP levels of 7.7±4.23 mg/dl at 2 months vs 2.41±1.5mg/dl at end 6 months and serum IFN-γ of 12.53±8.33 pg/ml at 2 months and 2.47±1.55 pg/ml at end of 6 months of ATT respectively with a statistically significant of p value < 0.00. Sputum IFN-γ levels were also elevated in cases with baseline values of 24.92±16.53 pg/ml which decreased to 7.68±5.17 pg/ml after 2 months and further to 3.86±3.12 pg/ml at end of 6 months of ATT respectively with a statistically significant of p value < 0.00.
In conclusion, our observations reveal that patients with APTB have significantly elevated serum CRP and IFN-γlevels compared to normal healthy individuals and these levels decrease significantly with duration of treatment. Therefore serum CRP and IFN-γlevels may be useful adjuvant markers in cases of APTB to monitoring response to treatment besides clinical and radiological feature who cannot produce adequate sputum in follow up.
Keywords: APTB: active pulmonary tuberculosis, ATT: anti-tubercular treatment, CRP: C-reactive protein, IFN-γ: Interferon gamma.
References
- Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins Basic Pathology(8th ed: (2007) pp. 516–522.
- "Tuberculosis Fact sheet N°104". World Health Organization November 2010.
- "Tuberculosis". World Health Organizations. 2002.
- TB Statistics for India. (2012).TB Facts. Retrieved April 3, 2013, from http://www.tbfacts.org/tb-statistics-india.html
- Munk ME, Emoto M. Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J Suppl. 1995;20: 668–675.
- Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb) 2003;83(1–3):98–106.
- Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 1994;84(12):4008–4027.
- Bhowmik, A., T. A. Seemungal, R. J. Saps-ford, J. L. Devalia, and J. A. Wedzicha. 1998. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 53:953-956.30.
- Petroff S. A. A new method for isolation and cultivation of tubercle bacilli from sputum and faeces. J Exp Med 1915;21: 38.
- Yamada G, Shijubo N, Shigehara K, Okamura H, Kurimoto M, Abe S. (2000): Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. Am J Respir Crit Care Med; 161:1786–9.
- Muhammed Khalid Shaikh, Javed Akhtar Samo, Bikha Ram Devrajani, Syed Zulfiquar Ali Shah, Samina Shaikh and Imran Shaikh.C - reactive protein in Patients with Pulmonary Tuberculosis. World Applied Sciences Journal 2012;17 (2): 140-44.
- Mohammad Shameem, Nazish Fatima, Asrar Ahmad, Abida Malik, Qayyum Husain. Correlation of Serum C-Reactive Protein with Disease Severity in Tuberculosis. Open Journal of Respiratory Diseases, 2012, 2, 95-100
- M Kannapiran, Chandra Immanuel, V Krishnamurthy, G Raghupati Sarma. C-Reactive Protein Levels In Patients With Pulmonary Tuberculosis. Lung India.Year : 1989, 7( 1):34-36
- Shahid HussainNadeem Afzal Khursheed Javaid · Muhammad IkramUllah · Tanveer Ahmad · Saleem-Uz-Zaman. Level of interferon gamma in the blood of tuberculosis patients. Iranian journal of immunology: IJI 12/2010; 7(4):240-6.
- A Verbon,N Juffermans, S J H Van Deventer, H Van Deutekom, and T Van Der Poll . Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin ExpImmunol. 1999 Jan; 115(1): 110–113.
- Ryu YJ, Ryu KH, Kim SH, Lee JS, Cheon SH, Seoh JY. Soluble IL-2R, IFN-gamma and Neopterin as Immunologic Markers in Patients with Tuberculosis. Tuberc Respir Dis. 2002 Sep;53(3):294-308.
- Sei Won Lee,Choon-Taek Lee, and Jae-Joon Yim. Serial interferon-gamma release assays during treatment of active tubercu-losis in young adults BMC Infectious Diseases 2010, 1471-2334-10-300.
- Rodrigo Ribeiro-Rodrigues, Tatiana Resende Co, John L. Johnson, Fabiola Ribeiro. Sputum Cytokine Levels in Patients with Pulmonary Tuberculosis as Early Markers of Mycobacterial Clearance. Clin Vaccine Immunol. 2002;6:(9) 818-823.
Corresponding Author
Mohd Yousoof Dar
Permanent Address: 1/3/SRS/Lane 16, House Number -044,
Syed Rehman Sahabbrein, Srinagar Kashmir
Pin Code - 191123 INDIA
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
DOI: https://dx.doi.org/10.18535/jmscr/v6i1.113
